In spite of evidence suggesting two possible mechanisms related to drug-seeking behavior, namely reward-seeking and harm avoidance, much of the addiction literature has focused largely on positive incentivization mechanisms associated with addiction. In this study, we examined the contributing neural mechanisms of avoidance of an aversive state to drug-seeking behavior during marijuana withdrawal. To that end, marijuana users were scanned while performing the monetary incentive delay task in order to assess positive and negative incentive processes. The results showed a group x incentive interaction, such that marijuana users had greater response in areas that underlie reward processes during positive incentives while controls showed greater response in the same areas, but to negative incentives. Furthermore, a negative correlation between withdrawal symptoms and response in the amygdala during negative incentives was found in the marijuana users. These findings suggest that although marijuana users have greater reward sensitivity and less harm avoidance than controls, that attenuated amygdala response, an area that underlies fear and avoidance, was present in marijuana users with greater marijuana withdrawal symptoms. This is concordant with models of drug addiction that involve multiple sources of reinforcement in substance use disorders, and suggests the importance of strategies that focus on respective mechanisms.
References
[1]
Jarvis MJ (1994) A profile of tobacco smoking. Addiction 89: 1371–1376.
[2]
Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 24: 97–129.
[3]
Koob GF, Le Moal M (2005) Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nature neuroscience 8: 1442–1444.
[4]
Koob GF, Le Moal M (2008) Addiction and the brain antireward system. Annual review of psychology 59: 29–53.
[5]
Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278: 52–58.
[6]
Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF (2000) Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 22: 581–594.
[7]
Filbey FM, Claus E, Audette AR, Niculescu M, Banich MT, et al. (2008) Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry. Neuropsychopharmacology 33: 1391–1401.
[8]
Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE (2009) Marijuana craving in the brain. Proceedings of the National Academy of Sciences of the United States of America 106: 13016–13021.
[9]
van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, et al. (2010) Chronic effects of cannabis use on the human reward system: An fMRI study. European Neuropsychopharmacology 20: 153–163.
[10]
Hommer DW, Bjork JM, Gilman JM (2011) Imaging brain response to reward in addictive disorders. Annals of the New York Academy of Sciences 1216: 50–61.
[11]
Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Heishman SJ, et al. (2007) Associations between Cloninger's temperament dimensions and acute tobacco withdrawal. Addict Behav 32: 2976–2989.
[12]
Pomerleau OF, Fagerstrom KO, Marks JL, Tate JC, Pomerleau CS (2003) Development and validation of a self-rating scale for positive- and negative-reinforcement smoking: The Michigan Nicotine Reinforcement Questionnaire. Nicotine Tob Res 5: 711–718.
[13]
Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A (2001) The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci 4: 943–947.
[14]
Cherek DR, Bennett RH, Kelly TH, Steinberg JL, Benowitz NL (1989) Effects of nicotine gum and tobacco smoking on human avoidance responding. Pharmacology, biochemistry, and behavior 32: 677–681.
[15]
Scott D, Hiroi N (2010) Emergence of dormant conditioned incentive approach by conditioned withdrawal in nicotine addiction. Biological psychiatry 68: 726–732.
[16]
Sanchis-Segura C, Spanagel R (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addiction biology 11: 2–38.
[17]
Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychological review 111: 33–51.
[18]
Eissenberg T (2004) Measuring the emergence of tobacco dependence: the contribution of negative reinforcement models. Addiction 99 Suppl 15–29.
[19]
Gottfried JA, O'Doherty J, Dolan RJ (2003) Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science 301: 1104–1107.
[20]
Baxter MG, Murray EA (2002) The amygdala and reward. Nat Rev Neurosci 3: 563–573.
[21]
Kim H, Shimojo S, O'Doherty JP (2006) Is avoiding an aversive outcome rewarding? Neural substrates of avoidance learning in the human brain. PLoS biology 4: e233.
[22]
Gloria R, Angelos L, Schaefer HS, Davis JM, Majeskie M, et al. (2009) An fMRI investigation of the impact of withdrawal on regional brain activity during nicotine anticipation. Psychophysiology 46: 681–693.
[23]
McClernon FJ, Kozink RV, Rose JE (2008) Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 33: 2148–2157.
[24]
Weiss F, Koob GF (2001) Drug addiction: functional neurotoxicity of the brain reward systems. Neurotoxicity research 3: 145–156.
[25]
Levin KH, Copersino ML, Heishman SJ, Liu F, Kelly DL, et al. (2010) Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug and alcohol dependence 111: 120–127.
[26]
Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, et al. (2006) Cannabis withdrawal among non-treatment-seeking adult cannabis users. The American journal on addictions/American Academy of Psychiatrists in Alcoholism and Addictions 15: 8–14.
[27]
Cooper ZD, Haney M (2008) Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addiction biology 13: 188–195.
[28]
First MB, Spitzer RL, Miriam G, Williams JBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. In: Institute NYSP, editor. New York: Biometrics Research.
[29]
Budney AJ, Moore BA, Vandrey RG, Hughes JR (2003) The time course and significance of cannabis withdrawal. J Abnorm Psychol 112: 393–402.
[30]
Roese N, Jamieson D (1993) Twenty years of bogus pipeline research: A critical review and meta-analysis. Psychological bulletin 114: 363–375.
[31]
Budney AJ, Moore BA (2002) Development and consequences of cannabis dependence. Journal of clinical pharmacology 42: 28S–33S.
[32]
Knutson B, Westdorp A, Kaiser E, Hommer D (2000) FMRI visualization of brain activity during a monetary incentive delay task. NeuroImage 12: 20–27.
[33]
Deichmann R, Gottfried JA, Hutton C, Turner R (2003) Optimized EPI for fMRI studies of the orbitofrontal cortex. NeuroImage 19: 430–441.
[34]
Freire L, Mangin JF (2001) Motion correction algorithms may create spurious brain activations in the absence of subject motion. Neuroimage 14: 709–722.
[35]
Freire L, Roche A, Mangin JF (2002) What is the best similarity measure for motion correction in fMRI time series? IEEE Transactions on Medical Imaging 21: 470–484.
[36]
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, et al. (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 Suppl 1S208–219.
[37]
Beckmann CF, Jenkinson M, Smith SM (2003) General multilevel linear modeling for group analysis in FMRI. Neuroimage 20: 1052–1063.
[38]
Worsley K, Marrett S, Neelin P, Vandal A, Friston K, et al. (1996) A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4: 58–73.
[39]
Worsley KJ (2001) Statistical analysis of activation images. Functional MRI: An Introduction to Methods: Ch. 14.
[40]
Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, et al. (2000) Automated Talairach atlas labels for functional brain mapping. Human Brain Mapping 10: 120–131.
[41]
Nestor L, Hester R, Garavan H (2010) Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users. NeuroImage 49: 1133–1143.
[42]
Beck A, Schlagenhauf F, Wustenberg T, Hein J, Kienast T, et al. (2009) Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol Psychiatry 66: 734–742.
[43]
Wrase J, Schlagenhauf F, Kienast T, Wustenberg T, Bermpohl F, et al. (2007) Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. NeuroImage 35: 787–794.
[44]
Schneider S, Peters J, Bromberg U, Brassen S, Miedl SF, et al. (2012) Risk taking and the adolescent reward system: a potential common link to substance abuse. Am J Psychiatry 169: 39–46.
[45]
Wilson SJ, Sayette MA, Delgado MR, Fiez JA (2008) Effect of smoking opportunity on responses to monetary gain and loss in the caudate nucleus. Journal of abnormal psychology 117: 428–434.
[46]
Bjork JM, Smith AR, Chen G, Hommer DW (2010) Adolescents, adults and rewards: comparing motivational neurocircuitry recruitment using fMRI. PloS one 5: e11440.
[47]
Delgado MR, Li J, Schiller D, Phelps EA (2008) The role of the striatum in aversive learning and aversive prediction errors. Philosophical transactions of the Royal Society of London Series B, Biological sciences 363: 3787–3800.
[48]
Cooper JC, Hollon NG, Wimmer GE, Knutson B (2009) Available alternative incentives modulate anticipatory nucleus accumbens activation. Social cognitive and affective neuroscience 4: 409–416.
[49]
Knutson B, Wimmer GE, Kuhnen CM, Winkielman P (2008) Nucleus accumbens activation mediates the influence of reward cues on financial risk taking. Neuroreport 19: 509–513.
[50]
Knutson B, Adams CM, Fong GW, Hommer D (2001) Anticipation of increasing monetary reward selectively recruits nucleus accumbens. The Journal of neuroscience : the official journal of the Society for Neuroscience 21: RC159.
[51]
Clithero JA, Reeck C, Carter RM, Smith DV, Huettel SA (2011) Nucleus accumbens mediates relative motivation for rewards in the absence of choice. Frontiers in human neuroscience 5: 87.
[52]
Salamone JD (1994) The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behavioural brain research 61: 117–133.
[53]
Schlund MW, Cataldo MF (2010) Amygdala involvement in human avoidance, escape and approach behavior. NeuroImage 53: 769–776.
[54]
Ehrlich I, Humeau Y, Grenier F, Ciocchi S, Herry C, et al. (2009) Amygdala inhibitory circuits and the control of fear memory. Neuron 62: 757–771.
[55]
Debiec J, Diaz-Mataix L, Bush DE, Doyere V, Ledoux JE (2010) The amygdala encodes specific sensory features of an aversive reinforcer. Nature neuroscience 13: 536–537.
[56]
Kahn I, Yeshurun Y, Rotshtein P, Fried I, Ben-Bashat D, et al. (2002) The role of the amygdala in signaling prospective outcome of choice. Neuron 33: 983–994.
[57]
Barad M, Gean PW, Lutz B (2006) The role of the amygdala in the extinction of conditioned fear. Biological psychiatry 60: 322–328.
[58]
Bolla KI, Eldreth DA, Matochik JA, Cadet JL (2005) Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage 26: 480–492.
[59]
Vaidya JG, Block RI, O'Leary DS, Ponto LB, Ghoneim MM, et al. (2012) Effects of chronic marijuana use on brain activity during monetary decision-making. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 37: 618–629.
[60]
Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, et al.. (2012) Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study. Addiction biology.
[61]
Cousijn J, Goudriaan AE, Ridderinkhof KR, van den Brink W, Veltman DJ, et al. (2012) Approach-bias predicts development of cannabis problem severity in heavy cannabis users: results from a prospective FMRI study. PloS one 7: e42394.
[62]
Bechara A (2005) Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective. Nature Neuroscience 8: 1458–1463.
[63]
Verdejo-Garcia A, Bechara A (2009) A somatic marker theory of addiction. Neuropharmacology 56 Suppl 148–62.
[64]
Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, et al. (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273–289.
